Toxicologic Pathology Nonclinical Safety Assessment (Original PDF from Publisher)

Toxicologic Pathology Nonclinical Safety Assessment (Original PDF from Publisher)

Publisher

CRC Press

Language

‎English

Edition

1st

Format

Publisher PDF

File Size

209.9 MB

ISBN-10

1439872104

ISBN-13

978-1439872109, 9781439872109

$21.00

5/5
Description

Toxicologic Pathology Nonclinical Safety Assessment (Original PDF from Publisher)

In the evolving landscape of pharmaceutical drug research, the focus on addressing unmet medical needs and the development of increasingly targeted therapies has ushered in the potential for previously unseen pharmacological or off-target effects in treatments.

Toxicologic Pathology Nonclinical Safety Assessment” is meticulously designed to serve as an invaluable resource for pathologists engaged in pharmaceutical drug research.

This book offers a comprehensive histopathological description of lesions encountered during drug development, while also delving into their implications within the drug development continuum.

Structured into two sections, the volume provides systematic guidance for pathologists in determining the origin, significance, and relevance of observed lesions in assessing human risk.

The first section offers essential conceptual insights, ensuring effective collaboration with fellow pathologists and multidisciplinary teams involved in drug development.

The second section, organized by organ, furnishes pathologists with detailed descriptions of lesions, differential diagnoses, biological consequences, pathogenesis, mechanism of lesion formation, and expected clinical pathology correlations.

With an emphasis on sharing both published and unpublished insights, drawn from professional experience, this book aims to enhance the quality of drug safety assessment and streamline the evaluation process.

Targeted at students, residents, and early-career toxicologic pathologists, this volume serves as an accessible reference, fostering confident decision-making beside the microscope.

Seasoned pathologists will also find it invaluable in their assessments, while toxicologists will gain essential background knowledge for addressing compound-related pathological findings and addressing a range of toxicological challenges.

Toxicologic Pathology Nonclinical Safety Assessment (Original PDF from Publisher)

Toxicologic Pathology Nonclinical Safety Assessment (Original PDF from Publisher)

1.2.Key Features

The best key features of “Toxicologic Pathology Nonclinical Safety Assessment” include:

  1. Comprehensive Lesion Descriptions: The book provides thorough histopathological descriptions of lesions encountered during drug development, aiding pathologists in their assessment and interpretation.
  2. Organ-Based Structure: Organ-based chapters offer both light and electron microscopic descriptions of pathological lesions, enabling a focused examination of specific areas of interest.
  3. Differential Diagnoses: Each organ-based chapter includes a discussion of differential diagnoses, helping pathologists consider alternative explanations for observed lesions.
  4. Biological Consequences: The book delves into the biological consequences of lesions, allowing pathologists to understand the potential impact on the patient.
  5. Pathogenesis and Mechanism: It provides insights into the pathogenesis and mechanism of lesion formation, enhancing pathologists’ understanding of the underlying processes.
  6. Clinical Pathology Correlations: Expected clinical pathology correlates are discussed, facilitating the connection between pathological findings and clinical outcomes.
  7. Conceptual Chapters: The book includes concept chapters to provide pathologists with essential insights and knowledge for effective collaboration with multidisciplinary teams in drug development.
  8. Experienced Insights: The book shares both published and unpublished insights gained through professional experience, enriching the content with practical wisdom.
  9. Resource for All Career Levels: It caters to students, residents, early-career pathologists, and experienced professionals, making it a valuable reference for a wide range of readers.

Toxicologic Pathology Nonclinical Safety Assessment” stands as a comprehensive and practical guide that equips pathologists with the knowledge and resources needed to navigate the complex field of pharmaceutical drug research, ensuring that they can effectively contribute to the assessment of drug safety and risk.

Toxicologic Pathology Nonclinical Safety Assessment (Original PDF from Publisher)

Toxicologic Pathology Nonclinical Safety Assessment

1.3. About Writer

Pritam S. Sahota, James A. Popp, Jerry F. Hardisty, and Chirukandath Gopinath, distinguished editors of “Toxicologic Pathology Nonclinical Safety Assessment,” collectively bring a wealth of expertise and experience to the field of toxicologic pathology.

Dr. Pritam S. Sahota, a renowned figure, has made significant contributions to the discipline, serving as a pathologist and contributing to the advancement of safety assessment practices.

Dr. James A. Popp, with extensive experience in toxicologic pathology, has played an influential role in educating future pathologists and professionals in the field.

Dr. Jerry F. Hardisty, a distinguished expert, has dedicated his career to understanding and addressing safety concerns in pharmaceutical research.

Dr. Chirukandath Gopinath, a respected contributor, has enriched the field with valuable insights.

Together, their collaborative effort in editing this book reflects their commitment to enhancing the quality of toxicologic pathology and its critical role in drug development and safety assessment.

Toxicologic Pathology Nonclinical Safety Assessment (Original PDF from Publisher)

Toxicologic Pathology Nonclinical Safety Assessment (Original PDF from Publisher)

Summary

Toxicologic Pathology Nonclinical Safety Assessment,” edited by Pritam S. Sahota, James A. Popp, Jerry F. Hardisty, and Chirukandath Gopinath, stands as a comprehensive guide for professionals engaged in pharmaceutical drug research.

This invaluable resource meticulously explores histopathological lesions encountered in drug development, shedding light on their origins and implications for human risk assessment.

The book is structured into two sections, offering conceptual insights crucial for interdisciplinary collaboration and organ-based chapters providing detailed lesion descriptions, differential diagnoses, biological consequences, pathogenesis, mechanisms of formation, and expected clinical correlations.

Drawing from both published and unpublished knowledge, the book aims to elevate the quality of drug safety evaluation and streamline the assessment process.

Whether for students, residents, early-career pathologists, or experienced professionals, this volume serves as an accessible reference to enhance decision-making in toxicologic pathology, bridging the gap between theoretical understanding and practical application in the pharmaceutical arena.

 

 

Make sure that you are buying e-books from trustworthy sources. With over a decade of experience in the e-book industry, the Medbook1.com website is a reliable option for your purchase.

 

Categories:

Clinical Specialties 

Toxicology 

 

Other Products:

Vanders Human Physiology The Mechanisms of Body Function 13th Edition (Original PDF from Publisher)

Vibrational Spectroscopy for Tissue Analysis (Series in Medical Physics and Biomedical Engineering) (Original PDF from Publisher)

Anatomy and Physiology Foundations for the Health Professions (Original PDF from Publisher)

 

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Toxicologic Pathology Nonclinical Safety Assessment (Original PDF from Publisher)”

Your email address will not be published. Required fields are marked *